Pharmaceutical

EC expands indication approval for Merck’s Ebola vaccine

The European Commission granted expanded indication approval for Merck’s Ebola vaccine, Ervebo, to include children aged one year or above.

Sep 9, 2023 - 20:00
EC expands indication approval for Merck’s Ebola vaccine
The European Commission granted expanded indication approval for Merck’s Ebola vaccine, Ervebo, to include children aged one year or above.
Read the original article

Tags:

Previous Article

NICE recommends Lilly’s tirzepatide to treat T2D

Next Article

Biocytogen and Myricx Bio partner for development of ADCs

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

He was named a MacArthur ‘genius’ fellow for research on gene regulation, but still has imposter syndrome

He was named a MacArthur ‘genius’ fellow for research o...

Oct 14, 2023

Why nearly half of Americans with Parkinson’s don’t see a neurologist

Why nearly half of Americans with Parkinson’s don’t see...

Jul 10, 2023

Machine learning could help predict risk of preterm birth using wearables data

Machine learning could help predict risk of preterm bir...

Sep 28, 2023